Cindy,

This has been the FDA's response to Wyeth, Martek and Mead Johnson:

>> The agency has not, however, made its own determination regarding the
GRAS status of the subject use of ARASCO and DHASCO.<<

See the following GRAS notices numbered 7 (Mar 1999), 41 (May 2001) and 80
(Dec 2001):

http://vm.cfsan.fda.gov/~rdb/opa-g007.html


http://www.cfsan.fda.gov/~rdb/opa-g041.html


http://www.cfsan.fda.gov/~rdb/opa-g080.html


Here's a link to a summary of all GRAS notices going back to 1998:

http://www.cfsan.fda.gov/~rdb/opa-gras.html


The milk-derived lactoferrin notices make for interesting reading, too.

HTH,

Pat W


-----Original Message-----
From: Lactation Information and Discussion
[mailto:[log in to unmask]]On Behalf Of Cindy Curtis
Sent: Tuesday, September 23, 2003 9:51 PM
To: [log in to unmask]
Subject: Re: Lipil


Can anyone tell me where to find on the fda site or other sites that the new
formulas are not approved?
Thanks
Cindy
  ----- Original Message -----

             ***********************************************

To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]

The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html